Effectiveness of a new drug, bredinin, on canine kidney allotransplant survival. 1979

H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi

BR has remarkable effectiveness on canine kidney allograft survival. Its effectiveness in suppression of the immune responses is dependent on the dosage. Atrophy of the spleen and the mesenteric lymph nodes is prominent in treated dogs. Septic complications are slight, with no reduction in the number of peripheral white blood cells. Erosive changes of the mucosa in the entire bowel are the major side effects of the drug treatment. Liver functional abnormality has not been observed.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008221 Lymphoid Tissue Specialized tissues that are components of the lymphatic system. They provide fixed locations within the body where a variety of LYMPHOCYTES can form, mature and multiply. The lymphoid tissues are connected by a network of LYMPHATIC VESSELS. Lymphatic Tissue,Lymphatic Tissues,Lymphoid Tissues,Tissue, Lymphatic,Tissue, Lymphoid,Tissues, Lymphatic,Tissues, Lymphoid
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D006460 Hemolysin Proteins Proteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS. Hemolysin,Hemolysins,Hemalysins,Proteins, Hemolysin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001284 Atrophy Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes. Atrophies
D012263 Ribonucleosides Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic

Related Publications

H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
January 1975, Eksperimental'naia khirurgiia i anesteziologiia,
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
January 1982, Urologiia i nefrologiia,
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
August 1984, Transplantation,
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
January 1973, Vestnik Akademii meditsinskikh nauk SSSR,
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
January 1981, Casopis lekaru ceskych,
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
January 2001, Transplantation proceedings,
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
January 1998, Klinichna khirurhiia,
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
January 2003, Hematology. American Society of Hematology. Education Program,
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
May 1973, Lancet (London, England),
H Uchida, and K Yokota, and N Akiyama, and Y Masaki, and K Aso, and M Okubo, and M Okudaira, and M Kato, and N Kashiwagi
November 2015, The New England journal of medicine,
Copied contents to your clipboard!